Shandong Weigao Orthopaedic Device Co Ltd
SSE:688161
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.38
36.64
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
S
|
Shandong Weigao Orthopaedic Device Co Ltd
SSE:688161
|
12.2B CNY |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.9B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
180.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
137.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135.7B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
128.7B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57.3B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.3B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.4B USD |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Shandong Weigao Orthopaedic Device Co Ltd
Glance View
Nestled in the bustling economic landscape of China, Shandong Weigao Orthopaedic Device Co Ltd has carved a respected niche for itself in the realm of medical equipment. The company, founded as a subsidiary of the larger Weigao Group, specializes in the design, production, and distribution of orthopedic devices. Its journey starts with an unwavering commitment to incorporating advanced technology into healthcare solutions. Shandong Weigao has honed its focus on spinal, trauma, and joint-related products, ensuring that its offerings meet international standards and cater to both domestic and global markets. Operating within an industry where precision and reliability are paramount, the company has leveraged a well-established network to distribute its products to hospitals, clinics, and healthcare facilities, thus embedding its roots deeply within the healthcare infrastructure. This thriving enterprise makes money by delivering value through its diverse product portfolio tailored to meet the complex and varied needs of orthopedic treatments. Its revenue model is centered around a combination of direct sales, strategic partnerships, and long-term contracts with healthcare providers. By engaging in continuous research and development, Shandong Weigao not only expands its product lines but also enhances existing solutions, ensuring they remain cutting-edge. This emphasis on innovation has enabled the company to maintain a competitive edge in a rapidly evolving market, positioning itself as a leader in China’s orthopedic device industry. Through strategic market penetration and an adept understanding of regulatory landscapes, Shandong Weigao Orthopaedic Device Co Ltd not only sustains its growth but also contributes significantly to the advancements in orthopedic healthcare.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Shandong Weigao Orthopaedic Device Co Ltd is 20.3%, which is above its 3-year median of 15.3%.
Over the last 3 years, Shandong Weigao Orthopaedic Device Co Ltd’s Operating Margin has decreased from 35.5% to 20.3%. During this period, it reached a low of 1.2% on Mar 31, 2024 and a high of 35.5% on May 30, 2022.